About us Contacts Interactions: 118 620
Drug search by name

ME/NaPhos/MB/Hyo1 and Myasthenia gravis

Result of checking the interaction of drug ME/NaPhos/MB/Hyo1 and disease Myasthenia gravis for safety when used together.

Check result:
ME/NaPhos/MB/Hyo1 <> Myasthenia gravis
Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Because antimuscarinic agents have anticholinergic effects, they are contraindicated in patients with myasthenia gravis. Their use may be appropriate to reduce adverse muscarinic effects caused by an anticholinesterase agent.

References:
  • "Product Information. Atropine Sulfate Injection, USP (atropine)." ESI Lederle Generics, Philadelphia, PA.
  • Shutt LE, Bowes JB "Atropine and hyoscine." Anaesthesia 34 (1979): 476-90
ME/NaPhos/MB/Hyo1

Generic Name: hyoscyamine / methenamine / methylene blue / sodium biphosphate

Brand Name: Urogesic-Blue, UTA, Uro-BLUE, Urolet MB, Indiomin MB, ME/NaPhos/MB/Hyo1, UTA

Synonyms: Hyoscyamine, methenamine, methylene blue, and sodium biphosphate, Methenamine, Methylene Blue, and Sodium Phosphate Monobasic

Interaction with food and lifestyle
Drug interactions